Paper Details
- Home
- Paper Details
Oxygen-ozone autohemotherapy in breast cancer patients suffering from fatigue and musculoskeletal pain upon aromatase inhibitors treatment: a case-series study.
Author: ChirumboloS, FisichellaR, FranziniM, PandolfiS, TirelliU, ValdenassiL
Original Abstract of the Article :
In patients with breast cancer and positive hormone receptors, aromatase inhibitors are effective in reducing the risk of recurrences and are active in progressing the disease in this setting. On the other hand, fatigue and painful musculoskeletal side effects can significantly reduce treatment comp...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.26355/eurrev_202312_34602
データ提供:米国国立医学図書館(NLM)
Oxygen-Ozone Autohemotherapy: A Potential Solution for Aromatase Inhibitor Side Effects in Breast Cancer?
This research explores the potential benefits of oxygen-ozone autohemotherapy in managing fatigue and musculoskeletal pain experienced by breast cancer patients receiving aromatase inhibitor treatment. The authors present a case-series study highlighting the potential of oxygen-ozone therapy in mitigating these side effects. They cite previous research demonstrating the effectiveness of oxygen-ozone therapy in treating pain and fatigue in patients with chronic fatigue syndrome, fibromyalgia, and other oncological conditions. This research suggests that oxygen-ozone therapy may offer a non-pharmaceutical approach to managing aromatase inhibitor side effects, potentially improving treatment compliance and quality of life for breast cancer patients.
Oxygen-Ozone Autohemotherapy: A Potential Adjunct to Aromatase Inhibitor Treatment
The study's findings suggest that oxygen-ozone therapy may offer a potential adjunct to aromatase inhibitor treatment for breast cancer patients, specifically for managing fatigue and musculoskeletal pain. The authors' previous research and the case-series presented in this study provide preliminary evidence for the potential benefits of this therapy in improving patient well-being. Further research is needed to confirm the efficacy of oxygen-ozone therapy and establish its role in managing aromatase inhibitor side effects.
Exploring Non-Pharmaceutical Options for Cancer Treatment
This research highlights the importance of exploring non-pharmaceutical options for managing cancer treatment side effects. Oxygen-ozone therapy, like a refreshing oasis in the desert of cancer treatment, offers a potential path to improve patient comfort and enhance overall quality of life. The authors encourage further investigation into the therapeutic potential of this therapy and other non-pharmaceutical approaches in cancer care.
Dr.Camel's Conclusion
Just as a camel caravan relies on the desert's natural resources for sustenance and healing, breast cancer patients may find relief in the natural properties of oxygen-ozone therapy. This research, like a desert oasis offering respite to weary travelers, highlights the potential of this non-pharmaceutical approach in managing the side effects of aromatase inhibitor treatment, providing a brighter and more comfortable journey for breast cancer patients.
Date :
- Date Completed n.d.
- Date Revised 2023-12-14
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.